Atreca Strikes Lucrative $12.5M Asset Sale Deal with Immunome, Boosting Novel Therapeutic Development
Atreca Secures Asset Sale Agreement with Immunome, Potentially Landing $12.5M DealCAMPBELL, Calif. - Atreca, Inc., a preeminent biotechnology firm, has announced a groundbreaking agreement to sell a collection of antibo...
Dec 26, 2023
Contract
